Praveen Nekkar's lab determines that depression medications can help treat Alzheimer’s disease
There are over half a million Canadians living with dementia. Treatment of this devastating disorder is challenging as there are no drugs available to cure it. Developing a new drug, running clinical trials, and acquiring approval from regulatory agencies is expensive and time-consuming: the process can take decades and cost upwards of 4 billion dollars.